Home -> Law Blog Directory -> Patent Law Blogs -> Patent Baristas
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent BaristasUpcoming Patent Events: Pharmaceutical and Biotech Patent Opinion Writing
By Stephen Albainy-Jenei
Billed as the ONE AND ONLY course where you will learn how to add value to your practice by drilling into the complex nuances of pharmaceutical and biotech patent opinion writing to reveal the strategies, solutions, and tactics for successfully tackling the issues, ACI?s Intensive Course in Pharmaceutical and Biotech Patent Opinion Writing will bring you an exceptional faculty with deep expertise in this complex area of patent law.
An evolving impact of In Re Seagate, conflicting views on the necessity of a patent opinion, and the massive cost factor combine with other issues to create critical, timely, and multidimensional considerations for pharmaceutical and biotech patent attorneys.
To break through these considerations, you must have a thorough understanding of the diverse approaches that the experts use in counseling their clients.
In the course, you will learn how to master the new challenges in the dynamic labyrinth of patent opinion writing in this exclusive course. This course is the ONE place where you will find patent attorneys with the passion, reputation, and resource of knowledge required to give you crucial insights on:
- What to put in writing, what to leave out
- Determining whether the client needs a patent opinion
- Mastering the core complexities of writing validity and non-infringement opinions
- Defining the elements of an effective FTO search
- Measuring the scope of the patent opinion
- Clarifying, incorporating, and forecasting the impact of In Re Seagate in your analysis
American Conference Institute’s Pharmaceutical and Biotech Patent Opinion Writing will be held in three choice locations:
- November 17-18, 2008, Boston, MA,
- December 8-9, 2008, Atlanta, GA
- January 12-13, 2009, San Diego, CA
Patent Baristas is a Media Partner for this Event.
Full post as published by Patent Baristas on August 12, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

Developments in Pharmaceutical and Biotech Patent Law
PLI Developments in Pharmaceutical and Biotech Patent Law Seminar
ACI Maximizing Pharmaceutical Patent Lifecycles Conference
Launching the Indian Generic Pharmaceutical Patent Academy
Patent Profile: Allele Biotech Announces Issuance of siRNA Patent
Biotech/Pharma Lobbying Scoreboard - Second Quarter Update








